RGC CIK: 1829667

Regencell Bioscience Holdings Ltd

  • Hong Kong
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26

Assets

(positive)
Change from FY22 to FY26
millions USD
FY22:
16.4
FY23:
11.6
FY24:
8.11
FY25:
4.90
FY26:
14.2
(positive)
Change from FY22 to FY26
millions USD
FY22:
1.57
FY23:
1.00
FY24:
0.32
FY25:
0.85
FY26:
0.51
Total assets
Change from FY22 to FY26
millions USD
FY22:
18.0
FY23:
12.6
FY24:
8.44
FY25:
5.76
FY26:
14.7

Liabilities & Equity

(negative)
Change from FY22 to FY26
millions USD
FY22:
0.58
FY23:
0.61
FY24:
0.19
FY25:
0.66
FY26:
1.32
(negative)
Change from FY22 to FY26
millions USD
FY22:
0.36
FY23:
0.03
FY24:
0.03
FY25:
0.23
FY26:
0.06
(positive)
Change from FY22 to FY26
millions USD
FY22:
17.1
FY23:
12.0
FY24:
8.22
FY25:
4.86
FY26:
13.3
Total liabilities & equity
Change from FY22 to FY26
millions USD
FY22:
18.0
FY23:
12.7
FY24:
8.44
FY25:
5.76
FY26:
14.7

All amounts in millions USD Data source:SEC EDGAR